The effect of imatinib and nilotinib on blood calcium and blood potassium levels in chronic myeloid leukemia patients: a literature review.

Autor: Prenggono, Muhammad Darwin¹ muh.darwin.prenggono@gmail.com, Yasmina, Alfi², Ariyah, Misna³, Wanahari, Tenri Ashari⁴, Hasrianti, Nuvita⁴

Publikováno v: Oncology Reviews. 2021, Vol. 15 Issue 2, p26-35. 10p.

Acetylsalicylic acid use is associated with reduced risk of out-of-hospital cardiac arrest in the general population: Real-world data from a population-based study

Autor: Eroglu, Talip E., Blom, Marieke T., Souverein, Patrick C., Yasmina, Alfi, de Boer, Anthonius, Tan, Hanno L.

Publikováno v: PLoS ONE, 17(6 June):e0267016. Public Library of Science
PLoS One, 17(6), 1. Public Library of Science
for the ESCAPE-NET investigators 2022, ' Acetylsalicylic acid use is associated with reduced risk of out-of-hospital cardiac arrest in the general population : Real-world data from a population-based study ', PLoS ONE, vol. 17, no. 6 June, e0267016 . https://doi.org/10.1371/journal.pone.0267016

Aim Activated blood platelet products facilitate myocardial intracellular Ca2+ overload, thereby provoking afterdepolarizations and increasing susceptibility of ischemic myocardium to ventricular fibrillation (VF). These effects are counteracted in v

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53ab4a10a797eea6e58cf8954bffb52d
https://research.vumc.nl/en/publications/c8615fa7-ce4b-49d2-bb6c-a1d3b26d0aec

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Patterns of antiplatelet drug use after a first myocardial infarction during a 10-years period

Autor: Yasmina, Alfi, de Boer, Anthonius, Deneer, Vera H M, Souverein, Patrick C, Klungel, Olaf H, Pharmacoepidemiology and Clinical Pharmacology, Afd Pharmacoepi & Clinical Pharmacology

Publikováno v: British Journal of Clinical Pharmacology, 83(3), 632. NLM (Medline)

AIMS: To assess antiplatelet use patterns after a first myocardial infarction (MI) and to evaluate the determinants of antiplatelet non-persistence. METHODS: This study was conducted in 4,690 patients from the Utrecht Cardiovascular Pharmacogenetics

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::c0dfebe98e2d20de90b18bf0a8716c89
https://dspace.library.uu.nl/handle/1874/362097